Answers are grounded in this paper and cite their sources.
Chronic hepatitis delta virus (HDV) infection exacerbates hepatitis B virus (HBV)-related liver disease.In Côte d'Ivoire, HDV is systematic not systematically screened among hepatitis B surface antigen (HBsAg)positive blood donors, and most regional estimates rely on anti-HDV serology, which indicates exposure but not active replication.This study aimed to determine HDV RNA replication positivity among HBsAgpositive blood donors followed at the Blood Donor Medical Follow-up Centre (CMSDS) of the National Blood Transfusion Centre of Côte d'Ivoire (CNTSCI), using nested reverse transcription polymerase chain reaction (RT-PCR).A cross-sectional study based on a non-probability convenience sample was conducted in March 2021.HDV RNA was detected by nested RT-PCR targeting two genomic regions (nucleotides 888-1122 and 313-485).Of 51 donors included, 75% were male (n = 38) and and mean age was 37 ± 9 years.HBV DNA results were available for 43 donors (84%).Among them, HDV RNA positivity was 88.9% (32/36) in those with detectable HBV viraemia and 100% (7/7) in those with undetectable viral load, giving an overall positivity 90.7% (39/43).This figure applies only to donors with available viral load data not the entire cohort of 51 donors.HDV RNA was also detected in donors receiving tenofovir disoproxil fumarate (TDF) with suppressed HBV viraemia.Given the convenience sample of donors already in follow-up care, findings are hypothesis-generating rather than population-level estimates.These results support larger representative studies and systematic HDV screening during follow-up of individuals with chronic HBV infection.
No takes yet. Share an insight, caveat, or question.
Jacques et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: